Tumor cell apoptosis mediated by cytoplasmic ING1 is associated with improved survival in oral squamous cell carcinoma patients

Oncotarget

Volumn 5, Issue 10, 2014, Pages 3210-3219

  Bose, Pinaki ^a   Thakur, Satbir S ^b   Brockton, Nigel T ^c   Klimowicz, Alexander C ^a,d   Kornaga, Elizabeth ^d   Nakoneshny, Steven C ^a   Riabowol, Karl T ^a,b   Dort, Joseph C ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c ALBERTA HEALTH SERVICES   (Canada)

^d TOM BAKER CANCER CENTRE   (Canada)

Author keywords

Apoptosis; AQUA; Head and neck squamous cell carcinoma; ING1; Oral squamous cell carcinoma

Indexed keywords

MESSENGER RNA; P33ING1B PROTEIN; PROTEIN BCL XL; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ING1 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL PEPTIDE;

ADJUVANT THERAPY; ADULT; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL DEATH; CELL KILLING; CYTOPLASM; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZING RADIATION; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; CELL NUCLEUS; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NUCLEAR PROTEINS; PROPORTIONAL HAZARDS MODELS; PROTEIN TRANSPORT; TISSUE ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 84902106858     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1907     Document Type: Article

References (30)

1. Bose P, Thakur S, Thalappilly S, Ahn BY, Satpathy S, Feng X, Suzuki K, Kim SW and Riabowol K. ING1 induces apoptosis through direct effects at the mitochondria. Cell Death Dis. 2013; 4:e788.
2. Soliman MA and Riabowol K. After a decade of study-ING, a PHD for a versatile family of proteins. Trends Biochem Sci. 2007; 32(11):509-519.
3. Scott M, Bonnefin P, Vieyra D, Boisvert FM, Young D, Bazett-Jones DP and Riabowol K. UV-induced binding of ING1 to PCNA regulates the induction of apoptosis. J Cell Sci. 2001; 114(Pt 19):3455-3462.
4. Scott M, Boisvert FM, Vieyra D, Johnston RN, Bazett-Jones DP and Riabowol K. UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences. Nucleic Acids Res. 2001; 29(10):2052-2058.
5. Kuzmichev A, Zhang Y, Erdjument-Bromage H, Tempst P and Reinberg D. Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1). Mol Cell Biol. 2002; 22(3):835-848.
6. Martin DG, Baetz K, Shi X, Walter KL, MacDonald VE, Wlodarski MJ, Gozani O, Hieter P and Howe L. The Yng1p plant homeodomain finger is a methyl-histone binding module that recognizes lysine 4-methylated histone H3. Mol Cell Biol. 2006; 26(21):7871-7879.
7. Pena PV, Hom RA, Hung T, Lin H, Kuo AJ, Wong RP, Subach OM, Champagne KS, Zhao R, Verkhusha VV, Li G, Gozani O and Kutateladze TG. Histone H3K4me3 binding is required for the DNA repair and apoptotic activities of ING1 tumor suppressor. J Mol Biol. 2008; 380(2):303-312.
8. Helbing CC, Veillette C, Riabowol K, Johnston RN and Garkavtsev I. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis. Cancer Res. 1997; 57(7):1255-1258.
9. Garkavtsev I, Kazarov A, Gudkov A and Riabowol K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat Genet. 1996; 14(4):415-420.
10. Gong W, Suzuki K, Russell M and Riabowol K. Function of the ING family of PHD proteins in cancer. Int J Biochem Cell Biol. 2005; 37(5):1054-1065.
11. Gunduz M, Demircan K, Gunduz E, Katase N, Tamamura R and Nagatsuka H. Potential usage of ING family members in cancer diagnostics and molecular therapy. Curr Drug Targets. 2009; 10(5):465-476.
12. Oki E, Maehara Y, Tokunaga E, Kakeji Y and Sugimachi K. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer. Cancer Lett. 1999; 147(1-2):157-162.
13. Toyama T, Iwase H, Watson P, Muzik H, Saettler E, Magliocco A, DiFrancesco L, Forsyth P, Garkavtsev I, Kobayashi S and Riabowol K. Suppression of ING1 expression in sporadic breast cancer. Oncogene. 1999; 18(37):5187-5193.
14. Vieyra D, Senger DL, Toyama T, Muzik H, Brasher PM, Johnston RN, Riabowol K and Forsyth PA. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors. Clin Cancer Res. 2003; 9(16 Pt 1):5952-5961.
15. Gong W, Russell M, Suzuki K and Riabowol K. Subcellulartargeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression. Mol Cell Biol. 2006; 26(8):2947-2954.
16. Yu L, Thakur S, Leong-Quong RY, Suzuki K, Pang A, Bjorge JD, Riabowol K and Fujita DJ. Src regulates the activity of the ING1 tumor suppressor. PLoS One. 2013; 8(4):e60943.
17. Guerillon C, Larrieu D and Pedeux R. ING1 and ING2: multifaceted tumor suppressor genes. Cell Mol Life Sci. 2013; 70(20):3753-3772.
18. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90.
19. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12):2893-2917.
20. Sanchez-Cespedes M, Okami K, Cairns P and Sidransky D. Molecular analysis of the candidate tumor suppressor gene ING1 in human head and neck tumors with 13q deletions. Genes Chromosomes Cancer. 2000; 27(3):319-322.
21. Tachibana M, Shinagawa Y, Kawamata H, Omotehara F, Horiuchi H, Ohkura Y, Kubota K, Imai Y, Fujibayashi T and Fujimori T. RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway. Anticancer Res. 2003; 23(3C):2891-2896.
22. Hoque MO, Kawamata H, Nakashiro K, Omotehara F, Hino S, Uchida D, Harada K, Begum NM, Yoshida H, Sato M and Fujimori T. Dysfunction of the p53 tumor suppressor pathway in head and neck cancer. Int J Oncol. 2002; 21(1):119-126.
23. Zhang JT, Wang DW, Li QX, Zhu ZL, Wang MW, Cui DS, Yang YH, Gu YX and Sun XF. Nuclear to cytoplasmic shift of p33(ING1b) protein from normal oral mucosa to oral squamous cell carcinoma in relation to clinicopathological variables. J Cancer Res Clin Oncol. 2008; 134(3):421-426.
24. Li XH, Noguchi A, Nishida T, Takahashi H, Zheng Y, Yang XH, Masuda S, Kikuchi K and Takano Y. Cytoplasmic expression of p33ING1b is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma. Histol Histopathol. 2011; 26(5):597-607.
25. Ythier D, Larrieu D, Brambilla C, Brambilla E and Pedeux R. The new tumor suppressor genes ING: genomic structure and status in cancer. Int J Cancer. 2008; 123(7):1483-1490.
26. Camp RL, Chung GG and Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med. 2002; 8(11):1323-1327.
27. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P and Moll UM. p53 has a direct apoptogenic role at the mitochondria. Mol Cell. 2003; 11(3):577-590.
28. Bose P, Klimowicz AC, Kornaga E, Petrillo SK, Matthews TW, Chandarana S, Magliocco AM, Brockton NT and Dort JC. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma. BMC Cancer. 2012; 12:332.
29. Thakur S, Feng X, Qiao Shi Z, Ganapathy A, Kumar Mishra M, Atadja P, Morris D and Riabowol K. ING1 and 5-azacytidine act synergistically to block breast cancer cell growth. PLoS One. 2012; 7(8):e43671.
30. Camp RL, Dolled-Filhart M and Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004; 10(21):7252-7259.